chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. The patients' pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On unknown dates, the patients were vaccinated orally with unknown doses of oral, ROTATEQ (lot # L008053, expiry date 30-NOV-2016), which were improperly stored - under temperature of 57.7F for 1 hour and 46.1F for 1 hour (cumulative 57.7F for 2 hours). There was no previous temperature excursion. No adverse effects were reported. Additional information has been requested.
Client c/o sore LD.  Minutes later c/o neck and shoulder pain.  Nurse called EMT to do vitals on client.  Client also explained that she was very nervous.  Vitals taken BP 129/69, HR 66, Resp 19.  Recheck BP 131/73. Client advised level of pain/discomfort down and released.
The patient experienced chronic inflammatory demylenating polyneuropathy, Idiopathic Tbrombocytopenic Purpurn(ITP), and gastric bleed after receiving ZOSTAVAX vaccine in 2016". The patient was hospitalized; The patient experienced chronic inflammatory demylenating polyneuropathy, Idiopathic Tbrombocytopenic Purpurn(ITP), and gastric bleed after receiving ZOSTAVAX vaccine in 2016". The patient was hospitalized; The patient experienced chronic inflammatory demylenating polyneuropathy, Idiopathic Tbrombocytopenic Purpurn(ITP), and gastric bleed after receiving ZOSTAVAX vaccine in 2016". The patient was hospitalized; Information has been received regarding a case in litigation involving an approximately 68 year old female patient (pt), reporting herself, with plantar fasciitis and drug reaction/allergy to nalidixic acid (NEGGRAM). Concomitant therapies included eltrombopag olamine (PROMACTA), gabapentin  and pantoprazole (indications not reported).     "Sometime on 2016", the pt was vaccinated with a dose of zoster vaccine live (ZOSTAVAX), for singles, in her arm (unspecified) (route, lot/batch # and expiration date were not reported).     It was reported that the pt experienced chronic inflammatory demylenating polyneuropathy (chronic inflammatory demyelinating polyradiculoneuropathy), Idiopathic Thrombocytopenic Purpurn (ITP) (immune thrombocytopenic purpura), and gastric bleed (gastric haemorrhage) after receiving zoster vaccine live (ZOSTAVAX) in 2016. Subsequently, the pt was hospitalized for about two weeks (unspecified date in 2016). The pt had a routine blood work on an unknown date, results not reported. She received immunoglobulin infusion as treatment on an unknown date.   The outcome of chronic inflammatory demyelinating polyradiculoneuropathy, gastric haemorrhage and immune thrombocytopenic purpura was reported as not resolved.  The causality assessment between chronic inflammatory demyelinating polyradiculoneuropathy, gastric haemorrhage and immune thrombocytopenic purpura with zoster vaccine live (ZOSTAVAX) was not reported.   The reporter considered chronic inflammatory demyelinating polyradiculoneuropathy, gastric haemorrhage and immune thrombocytopenic purpura as disabling and life threatening, however, it was also reported that no intervention was need to prevent serious criteria.   Upon internal review, chronic inflammatory demyelinating polyradiculoneuropathy, gastric haemorrhage and immune thrombocytopenic purpura were determined to be medically significant events.
Patient denies any vaccine associated symptoms. No acute distress reported,patient denying any issues. reports overall better. No adverse event occured.
My husband was sleeping the night of getting his 2nd Moderna Vaccination...  He, during his sleep, had a SEVERE Grand Mal Seizure with NOTHING leading up to it and NO PREVIOUS HISTORY WHATSOEVER of having ANY Seizures in his lifetime, nor ANY Epilepsy...  EVER! It was TERRIFYING, to me - I ran to his bedside (I happened to be in the livingroom watching television) after hearing loud grunts and a crash and came to find him convulsing, severely spewing blood and frothing at the mouth.  Grunting, convulsing, and thrashing.  Stiffening, arms and hands (both in a fist) tight and stiff in front of his chest, legs straight, rigid as a board and thrashing about spitting blood, eyes rolled back in his head.  As things began to becoming a little less severe, while waiting for the Fire Dept & EMTs to arrive I felt his legs which were hit to the touch and his face was drenched in sweat! With NEVER EXPERIENCING Anything like this before, and after 30 years of marriage, I thought my husband was dying ???????? He did NOT go with the EMTs, since once he was awake and somewhat cognitive we realized he was over it for the moment and we're in a wait and see basis. He saw our GP first thing the next morning.
slight headache around 4:00 p.m.; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8727) via an unspecified route of administration on 19May2021 at 14:45(at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19May2021, at 16:00 the patient experienced slight headache. The clinical outcome of the event slight headache was recovered on unknown date May2021.   No follow-up attempts are needed. No further information is expected.
Vaccine administered 9/24/14, developed pruritus 9/28/14, now indurated, erythematous warm to touch area noted (L) upper arm.
Rash with blisters neck, right side of chest and back all on the right side not crossing midline.
Myalgia, NauseaVomiting, FATIGUE, SEVERE ABDOMINAL CRAMPING Narrative:
Approximately 16 hrs after shots patient had a seizure, and was taken to the emergency room. Emergency room Dr. diagnosed patient with double ear infection along with fever. Patient was released from E.R. at around 2:30 p.m. on 02/24/2005.
Hair loss after both doses; This is a spontaneous report from a contactable consumer (patient herself).  A 35-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: er8736, expiration date was not reported), via an unspecified route of administration, in left arm on 23Apr2021 at 09:30 AM (at the age of 35-years-old) as dose 1, single and patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunization. The patient medical history included irritable bowel syndrome (IBS) and eczema. The patient had no known allergies. The patient was not pregnant at the time of vaccination. The patients concomitant medications were not reported. The patient had not received any other vaccine within 4 weeks and had not received other medications in two weeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 26Apr2021, the patient had experienced hair loss after both doses. Patient had not received any treatment for the event reported. The outcome of the event was recovering. Follow up attempts are needed. Further information has been requested.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected
Fainted at approximately 6:30 AM on 11/07/21 Prior to fainting, had low grade fever, chills, body aches, joint aches, tiredness diarrhea and nausea.  Continue to feel dehydrated and tired with less severe body and joint aches. Felt hot and light-headed today at 07:45 AM. Lasted about 5-10 minutes. Dissipated upon drinking water & eating.
Fatigue; fever 99.6 F; headache; myalgias; This is a spontaneous report from a contactable physician (patient). A 64-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899, expiry date not reported), via an unspecified route of administration in the left arm on 19Dec2020 08:45 at single dose, and then second dose (lot number: EK9231, expiry date not reported), via an unspecified route of administration in the left arm on 09Jan2021 08:00 at single dose for COVID-19 immunisation. Medical history included COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications were not reported. On 03Jan2021 11:00, the patient experienced fatigue, fever 99.6 F, headache and myalgias. Therapeutic measures were taken as a result of the events that included Rest Tylenol Motrin. Clinical outcome of the events was recovered on an unspecified date.
Rapid heart rate; This is a spontaneous report from a contactable consumer, the patient. A 60 Years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE (Lot number: Er 2613) via an unspecified route of administration in left arm on 17Mar2021at 1600, as single dose for COVID-19 immunisation. The patients medical history and concomitant medications were not reported.  Patients past drug history included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE (Lot number: EN6198) via unspecified route of administration in left arm on 24Mar2021 at 1645, as a single dose for COVID 19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination had not been tested for COVID-19.   On 17Mar2021at 1730, the patient experienced rapid heart rate with 100 bpm. The patient did not receive any treatment for the event. Clinical outcome of rapid heart rate was recovering at the time of reporting.  No further information is expected.
neck achy, face with burning sensation, neck with rash, itching, burning. Warmth on face started within 4 days of receiving the vaccine
Fatigue, 2/2/21 Chills, low grade (99.6 - 100.2) fever, body aches, 2/3/, 2/4, 2/5/2021 - Mild during day, low grade fever at night. Controlled with Tylenol and Aleve
No adverse symptoms reported; the patient received a third dose of MMRII on 07/21/2020 despite receiving two doses already; This spontaneous report was received from a consumer (the patient's mother) refers to a female patient of unknown age. Information regarding her concurrent conditions, medical history, drug reactions or allergies and concomitant therapies was not provided.  On unknown dates, the patient was vaccinated with her first and second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, lot number, route of administration, anatomical location were not provided) for prophylaxis. On 21-JUL-2020, she received a third, extra dose (despite receiving two doses already) of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, lot number, route of administration, anatomical location and strength were not provided) that she should not have gotten. There were no adverse symptoms reported.
Threw up; Threw up; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of VOMITING (Threw up) and the second episode of VOMITING (Threw up) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced the first episode of VOMITING (Threw up). On 06-Mar-2021, the patient experienced the second episode of VOMITING (Threw up). On 06-Mar-2021, last episode of VOMITING (Threw up) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
a little soreness in the arm; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "a little soreness in the arm". Therapeutic measures were taken as a result of pain in extremity. Additional information: The patient received unspecified medication as treatment for the event.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021302500 Same reporter, suspect drug, and event; different patient
Patient's eyes rolled upwards, and he fell backwards and was briefly unconscious (1-3 seconds). He was pale, recovered over 5-10 minutes, and ambulated out of the clinic with his mother. He had eaten no breakfast this morning.
The patient was administered an expired vaccination on August 24, 2022. The vaccination expired on August 22, 2022. No reactions were noted at the time or reported. Staff instructed on the importance for checking vaccines before administering, doing monthly inventory  and to remove all expired vaccines from storage.
I had a breakthrough case of Covid-19 took a home test it was positive did a telehealth visit where I was prescribed Paxlovid had fever but never lost smell or taste senses felt tired for about 5 days.
sweating; chills/shivering; Shivering; low grade fever; Feels confused; memory issues; Pain in Left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in Left arm), CONFUSIONAL STATE (Feels confused), MEMORY IMPAIRMENT (memory issues), HYPERHIDROSIS (sweating) and CHILLS (chills/shivering) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in Left arm). On 23-Apr-2021, the patient experienced CONFUSIONAL STATE (Feels confused) and MEMORY IMPAIRMENT (memory issues). On 24-Apr-2021, the patient experienced HYPERHIDROSIS (sweating), CHILLS (chills/shivering), CHILLS (Shivering) and PYREXIA (low grade fever). At the time of the report, PAIN IN EXTREMITY (Pain in Left arm), CONFUSIONAL STATE (Feels confused), MEMORY IMPAIRMENT (memory issues), HYPERHIDROSIS (sweating), CHILLS (chills/shivering), CHILLS (Shivering) and PYREXIA (low grade fever) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable. Relevant concomitant medications included Birth control pills.  Treatment information was not provided.
palpitations, tachycardia, fever, dizziness, shortness of breath, chest tightness, flank pain, headache, muscle  pain, chills
pt recv vax 24MAR98 & pt died from SIDS 4APR98 presented @ hosp;
Follow-up information received on 07/30/02 from the physician provided the county name, confirmation that no tests were done, the child was on no other medications and that the child recovered. A consumer reported that her 5 year old daughter accidentally received on dose of Prevnar (pneumococcal 7- valent conjugate vaccine in her left hip on 06/17/02. The child was scheduled to receive MMR (measle,mumps, rubella) vaccine, but  was given Prevnar instead, in addition to receiving diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (manufacturer unknown) in her left leg, and Polio Vaccine 'pasteur" (poliomyelitis vaccine inactivated in her right leg. Medical history includes language processing delay On 06/18/02, she developed an injection site reaction characterized by a red, painful area. The area initially measured 1 inch in diameter and grew to 1- 1/4 inches in diameter On 06/19/02, the area was a "little elevated" and 'felt hard' around the area. The daughter already received Prevnar about 2 years ago (in 2000)
Patient received bivalent COVID-19 booster on 9/3/22 at approximately 10.5 weeks gestation.  Seen for routine 12 week OB visit on 9/12/22.  Fetus with +FHR at that time.  Presented on 10/10/22 for 16 week OB visit and diagnosed with fetal demise, measuring approximately 11 weeks 6 days.   Initial EDC:  3/27/23.  Underwent D&E for management of fetal demise.
Seen in office 6/13/11 because exposed to 9 y/o playmate diagnosed with pertussis in past couple days. Patient complained of cough since 6/9/11. Afebrile. Up to date on vaccines. PCR done & given Rx for ZITHROMAX 240 mg x 1d & 120 mg x 4d to start. Positive PCR reported 6/16/11.
Unable to sleep the night after receiving vaccine (unusual), soreness in arm, skin sensitive and sore all over (clothes causing discomfort), fever of 100.2 upon waking, severe headache, cramping in lower back and legs, extreme fatigue
I contracted shingles at the middle of March. Because of the rash and pain I went to the doctor's and they gave me medicine for.
Case number PHEH2014US001600 is an initial spontaneous report from the pharmacist received on 16 Jan 2014. This report refers to a 15-year-old male patient who was accidentally vaccinated with 0.5 ml of FLUCELVAX (batch number: not reported) intramuscularly on 10 Dec 2013. No adverse event reported following this medication error. Following an internal review on 18 Aug 2014, a significant correction was done for the information received on 16 Jan 2014: The labeling of the event "inappropriate age at vaccine administration" changed from listed to unlisted and added second indication as "drug used in unapproved population".
Dizziness 6 days after vaccination. Woke up with dizziness and vertigo while lying down
PATIENT RECEIVED UNDILUTED PFIZER COVID DOSE.  DAY AFTER RECEIVING DOSE, SHE STARTED TO FEEL HOT AND COLD AT THE SAME TIME AND ANXIOUS AND SHAKEY. FEVER IN WAVES, THEN CHILLS, AND ACHES.  FELT VERY TIRED.
Patient presents today that she had an MMR II performed on September 6. She states that following the MMR II just beginning yesterday she had a very red and uncomfortable at the posterior portion of her right arm. She states that it was tingling this morning and was sensitive to touch. However, that has subsided. She continues to have the warmth and firm area under the skin. She is concerned that something else may be going on like an allergic reaction. She denies any shortness of breath or any rash elsewhere. She has no fever, chills, lightheadedness, or dizziness. Evaluation reveals a 4 cm indurated area at the right posterior arm at the injection site. The area is warm to touch and only mildly tender. There is no surrounding erythema noted. Patient has full range to motion of the arm. There is no fluctuance whatsoever noted at this point. No other findings. The case was discussed with Dr. as well. Cellulitis at the right posterior arm, possibly a localized reaction secondary to the MMR II; however, this seems unlikely due to the duration from that. It is possible there could be a sterile abscess forming. Patient was placed on BACTRIM DS, 1 tab p.o. b.i.d., #20 dispensed. She was advised to use hot compresses 15-20 minutes at a time for the next several days, doing that approximately four times daily. She was advissed to also try ibuprofen to treat her symptoms for discomfort, taking three tablets of the 200 mg ibuprofen q.6h. as needed, and she will follow up on Monday for reevaluation. She will present to emergency facility should her symptoms worsen over the weekend or she becomes more concerned regarding the reaction. Nurse in Immunization was notified and patient will be seen there as well for a brief evaluation.
2nd Anthrax vax administered ?? at 14:00. Noted to have short swelling 24 hrs later. Presented today with moderated edema/erythema to upper arm from shoulder to elbow. Warmth right = 35 cm, left = 30 cm red arm measure? circulatory/ ?? implement Treated w/steroid, Benadryl.
Medical team dispatched to the residence of the the name person on April 10, 2021 at 2327. Pt assessed by medic on scene and determine patient with obvious death. Pt found halfway on the couch and to be pulseless, apneic, and with rigor mortis. Unknown down time and when further assessed, patient death determine by EMS.   pt had fixed and dilated pupils, non-responsive to painful stimuli, absent breath sounds, no heart sounds auscultated. Pt was also placed on the monitor and found to be in asystole in 2 contiguous leads. CPR with held and no resuscitative measures performed.
Completely feeling fine prior to receiving shingles virus shot.  Took 2 Tylenol.  At 2 AM bad headache, took 2 more Tylenol.  Site of shot became red, pain & swelled.  Became hoarse & started cough, then nose congestion & achy body muscles.  Still ongoing now.  Temp. was not taken.
This spontaneous report was received from a female patient of unknown age, referring to herself. The patient's pertinent medical history, drug reactions and allergies and concomitant therapy were not reported. On an unspecified date in January 2017, the patient was vaccinated with a dose of ZOSTAVAX (dose, route of administration, lot # and expiration date were not reported) for prevention of shingles. On an unspecified date in March 2017, the patient was diagnosed with lobular breast cancer. The outcome the adverse event was not reported. The relatedness between the adverse event and ZOSTAVAX was not reported. Upon internal review, the adverse event of lobular breast cancer was determined to be medically significant. Additional information is not expected, as there was no consent to contact.
Started with a burning pain both of her arms. Her arms are very achy and feel like she was lifting weights for hours- mostly described in biceps, feeling of early fatigue.
His platelets has falling and was hospitalized; This is a spontaneous report from a contactable consumer (patient).   A 61-year-old male patient received second dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in right arm on 16Mar2021 08:30 (Lot Number: En6199), at the age of 61-years at vaccination, as SINGLE DOSE for COVID-19 immunisation.  Medical history included Cancer immune compromised. The patient did not have COVID-19 prior vaccination. Historical vaccine includes first dose of BNT162B2 on 23Feb2021. Concomitant medications included aspirin; ticagrelor (BRILINTA); amlodipine besilate, ramipril (COREYRA); cetirizine hydrochloride (ZYRTEC); sacubitril valsartan sodium hydrate (ENTRESTO), all were taken for unspecified indication, start and stop date were not reported.  His platelet count on 05Feb2021 was 182. First shot on 23Feb2021. His platelet count on 05Mar2021 was 113. His 2nd shot was on 16Mar2021. His platelet count on 04Apr2021 was 47. His platelets was falling on 23Mar2021 (reported event onset) and was hospitalized for 8 days. Received platelets and waiting bone marrow biopsy results. Event required ER and physician office visit.  The patient was tested for COVID post vaccination, with unknown results. The outcome of the event was unknown.
Clusters of cold sores around mouth and in nose after 3 years of not having any. I take a daily dosage of Valtrex (1gm).